Pharmacist at drug compounder NECC convicted, but not of murder

New England Compounding Center's contaminated drugs caused a fungal meningitis outbreak that killed more than 60 people.

The co-owner of New England Compounding Center, whose contaminated drugs caused a fungal meningitis outbreak that killed more than 60 people, has been convicted of dozens of federal charges but acquitted of murder.

A jury in Boston convicted Barry J. Cadden of more than 50 counts of mail fraud for his part in peddling unsterile drugs that led to a national outbreak of fungal meningitis in 2012 that infected more than 750 patients and killed 60. Sentencing was set for June, the Boston Globe reported.

Cadden was chief pharmacist as well as an owner of the now-defunct drug compounding business, whose contaminated steroids were injected into people’s spines. While a majority of jurors voted to convict the 50-year-old Cadden of 23 of the 25 murder charges filed against him, a unanimous decision couldn’t be reached, probably sparing Cadden a life sentence, the newspaper reports.


The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

Authorities found unsterile conditions in the area where the contaminated steroids implicated in the outbreak had been manufactured. 

The outbreak shined a spotlight on the rapid growth of the drug compounding industry, from small local pharmacy operations to large companies mass-producing drugs and using national sales forces to market them. The public outcry over the episode led to passage of the Drug Quality and Security Act, which gives the FDA new, but limited, powers to oversee compounding pharmacies that volunteer to be regulated.

Fourteen people were indicted in the case, but only Cadden and supervisory pharmacist Glenn A. Chin were charged with murder. Chin, who also pleaded not guilty, has yet to be tried. Last year, NECC majority shareholders Carla Conigliaro and her husband Douglas pleaded guilty to related charges for trying to hide $33 million in assets after the pharmacy went into bankruptcy and a court ordered all assets frozen.

Suggested Articles

Bristol-Myers Squibb is out to expand the pool of colorectal cancer patients it can treat with Opdivo—and it’s bringing in Bayer to help.

When AstraZeneca sold its Avlon, England plant in 2016, it thought its liabilities were over. Former employees said the drugmaker broke its promises.

Novartis' AveXis will use Catalent for some manufacturing of its newly approved gene therapy Zolgensma and more manufacturing news of note.